LENZ THERAPEUTICS, INC. (LENZ) Net Margin
- 2026-06-30: Net Margin -581.81%.
- 2026-03-31: Net Margin -2182.43%.
- 2025-12-31: Net Margin -2260.45%.
- 2025-09-30: Net Margin -133.60%.
Complete source-backed net margin history.
- Available history
- 2025-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -581.81% |
| 2026-03-31 | -2182.43% |
| 2025-12-31 | -2260.45% |
| 2025-09-30 | -133.60% |
| 2025-06-30 | -298.24% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -430.25% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |